Retractable Technologies, Inc. designs, develops, manufactures, and markets safety medical products for the healthcare industry in the United States and internationally. It principally offers VanishPoint safety products comprising tuberculin, insulin, and allergy antigen syringes; autodisable syringes; IV catheters; blood collection tube holders; and blood collection sets, as well as Patient Safe products, including syringes and Luer caps. The company also develops EasyPoint needles. In addition, it is developing retractable needles and syringes, glass syringes, dental syringes, and IV catheter introducers. Retractable Technologies, Inc. serves healthcare providers, such as acute care hospitals, alternate care facilities, doctors' offices, clinics, emergency centers, surgical centers, long-term care facilities, veterans administration facilities, military organizations, public health facilities, and prisons. The company distributes its products through general line and specialty distributors, as well as through international distributors; and a direct marketing network. Retractable Technologies, Inc. was founded in 1994 and is headquartered in Little Elm, Texas.
Industry, Sector and Symbol
Industry Medical Instruments & Supplies
Sub-IndustryN/A
SectorMedical
Phone+1-972-2941010
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
Employees123
Next Earnings Date4/3/2020 (Estimated)
OptionableNot Optionable
Retractable Technologies (NYSEAMERICAN:RVP) Frequently Asked Questions
What is Retractable Technologies' stock symbol?
Retractable Technologies trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "RVP."
How were Retractable Technologies' earnings last quarter?
Retractable Technologies, Inc. (NYSEAMERICAN:RVP) released its earnings results on Thursday, November, 15th. The company reported ($0.01) EPS for the quarter. The company had revenue of $9.86 million for the quarter. View Retractable Technologies' Earnings History.
When is Retractable Technologies' next earnings date?
Has Retractable Technologies been receiving favorable news coverage?
News headlines about RVP stock have trended neutral this week, according to InfoTrie Sentiment. InfoTrie identifies negative and positive news coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Retractable Technologies earned a media sentiment score of 0.5 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 1.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the company's share price in the next few days. View News Stories for Retractable Technologies.
Are investors shorting Retractable Technologies?
Retractable Technologies saw a increase in short interest in January. As of January 31st, there was short interest totalling 46,500 shares, an increase of 42.2% from the January 15th total of 32,700 shares. Based on an average daily trading volume, of 139,600 shares, the short-interest ratio is presently 0.3 days. Approximately 0.5% of the shares of the stock are short sold. View Retractable Technologies' Current Options Chain.
Who are some of Retractable Technologies' key competitors?
Some companies that are related to Retractable Technologies include InfuSystem (INFU), Bovie Medical (BVX), Tristel (TSTL), SDI (SDI), Milestone Scientific (MLSS), IsoRay (ISR), IsoRay (ISR), Impression Healthcare (IHL), TSO3 (TOS), Daxor (DXR), Daxor (DXR), G Medical (GMV), TransEnterix (TRXC), Omega Diagnostics Group (ODX) and Akers Biosciences (AKR).
What other stocks do shareholders of Retractable Technologies own?
Who are Retractable Technologies' key executives?
Retractable Technologies' management team includes the folowing people:
- Mr. Thomas J. Shaw, Founder, Chairman, Pres & CEO (Age 68)
- Ms. Michele M. Larios, VP, Gen. Counsel & Sec. (Age 53)
- Ms. Kathryn M. Duesman, Exec. Director of Global Health (Age 56)
- Russell B. Kuhlman, VP of Sales Devel. (Age 65)
- Mr. John W. Fort III, Director, VP, CFO, Principal Accounting Officer & Treasurer (Age 50)
Who are Retractable Technologies' major shareholders?
Retractable Technologies' stock is owned by a variety of of retail and institutional investors. Top institutional investors include Renaissance Technologies LLC (3.18%), Fosun International Ltd (0.23%), WealthTrust Axiom LLC (0.21%) and Virtu Financial LLC (0.05%). Company insiders that own Retractable Technologies stock include Thomas J Shaw and W Whitney George. View Institutional Ownership Trends for Retractable Technologies.
Which major investors are selling Retractable Technologies stock?
Which major investors are buying Retractable Technologies stock?
RVP stock was acquired by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC and Virtu Financial LLC. Company insiders that have bought Retractable Technologies stock in the last two years include Thomas J Shaw and W Whitney George. View Insider Buying and Selling for Retractable Technologies.
How do I buy shares of Retractable Technologies?
Shares of RVP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Retractable Technologies' stock price today?
One share of RVP stock can currently be purchased for approximately $1.74.
How big of a company is Retractable Technologies?
What is Retractable Technologies' official website?
How can I contact Retractable Technologies?
Retractable Technologies' mailing address is 511 Lobo Ln, LITTLE ELM, TX 75068-5295, United States. The company can be reached via phone at +1-972-2941010.
MarketBeat Community Rating for Retractable Technologies (NYSEAMERICAN RVP)
MarketBeat's community ratings are surveys of what our community members think about Retractable Technologies and other stocks. Vote "Outperform" if you believe RVP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RVP will underperform the S&P 500 over the long term. You may vote once every thirty days.
